These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 9225693)
1. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646 [TBL] [Abstract][Full Text] [Related]
3. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease. Lucotte G; Aouizérate A; Gérard N; Turpin JC; Landais P Am J Med Genet; 1995 Dec; 60(6):566-9. PubMed ID: 8825898 [TBL] [Abstract][Full Text] [Related]
4. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease]. Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127 [TBL] [Abstract][Full Text] [Related]
5. Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives. Pérez-Tur J; Campion D; Martinez M; Brice A; Tardieu S; Hannequin D; Agid Y; Delacourte A; Clerget-Darpoux F; Chartier-Harlin MC Am J Med Genet; 1995 Dec; 60(6):550-3. PubMed ID: 8825894 [TBL] [Abstract][Full Text] [Related]
6. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191 [TBL] [Abstract][Full Text] [Related]
7. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173 [TBL] [Abstract][Full Text] [Related]
8. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. van Duijn CM; de Knijff P; Wehnert A; De Voecht J; Bronzova JB; Havekes LM; Hofman A; Van Broeckhoven C Ann Neurol; 1995 May; 37(5):605-10. PubMed ID: 7755355 [TBL] [Abstract][Full Text] [Related]
9. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358 [TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T; Zhou X; Jin W; Zheng F; Cao X Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232 [TBL] [Abstract][Full Text] [Related]
11. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression. Butters MA; Sweet RA; Mulsant BH; Ilyas Kamboh M; Pollock BG; Begley AE; Reynolds CF; DeKosky ST Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138 [TBL] [Abstract][Full Text] [Related]
12. Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease. Lucotte G; Visvikis S; Leininger-Müler B; David F; Berriche S; Réveilleau S; Couderc R; Babron MC; Aguillon D; Siest G Am J Med Genet; 1994 Sep; 54(3):286-8. PubMed ID: 7810590 [TBL] [Abstract][Full Text] [Related]
13. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases. Itabashi S; Arai H; Matsui T; Matsushita S; Muramatsu T; Higuchi S; Trojanowski JQ; Sasaki H Exp Neurol; 1998 Jun; 151(2):237-40. PubMed ID: 9628759 [TBL] [Abstract][Full Text] [Related]
14. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Frisoni GB; Govoni S; Geroldi C; Bianchetti A; Calabresi L; Franceschini G; Trabucchi M Ann Neurol; 1995 May; 37(5):596-604. PubMed ID: 7755354 [TBL] [Abstract][Full Text] [Related]
16. [The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset]. Kurz A; Lautenschlager N; Haupt M; Zimmer R; von Thülen B; Altland K; Lauter H; Müller U Nervenarzt; 1994 Nov; 65(11):774-9. PubMed ID: 7816154 [TBL] [Abstract][Full Text] [Related]
17. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
18. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease. Kowalska A; Florczak J; Pruchnik-Wolińska D; Kraszewski A; Wender M Arch Immunol Ther Exp (Warsz); 1998; 46(3):177-81. PubMed ID: 9704150 [TBL] [Abstract][Full Text] [Related]